Overview
The staff within the Gene Transfer, Targeting and Therapeutics Viral Vector Core provide expert consultation for the safe and effective use of viral vector technologies, and offer custom design and production services for multiple viral vector types. The Gene Transfer, Targeting and Therapeutics Viral Vector Core facilitates the use of these powerful research tools by Salk researchers and others across diverse fields of study such as systems neuroscience, stem cell biology, metabolism, aging, cancer biology and gene therapy.
The U.S. Bureau of Industry and Security has updated the Export Administration Regulations regarding rabies vectors. We are now able to distribute reagents that contain any portion of the rabies genome only to countries that are part of the Australia Group:
https://www.dfat.gov.au/publications/minisite/theaustraliagroupnet/site/en/participants.html
National Cancer Institute
The GT3 core is a designated Cancer Center Council (C3) core facility. Cancer Center members from participating C3 institutes receive shared resource rates.
For submitting manuscripts that have made use of services or resources from this core, PLEASE ACKNOWLEDGE SUPPORT by inclusion of the following information:
“This work was supported by the GT3 Core Facility of the Salk Institute with funding from NIH-NCI CCSG: P30 CA01495”. Please
acknowledge core staff where appropriate and consider authorship inclusion when scientific contributions merit.
Please link each publication stemming from work performed in the core to your MyNCBI account. This will ensure that the contributions from NIH are appropriately acknowledged in renewal and continuation applications. This NIH requirement must be satisfied as part of our efforts to provide consistent access to stabling funded core resources. Information on how to link publications can be found here»
10010 N Torrey Pines Rd
La Jolla, CA 92037
Telephone: (858) 453-4100
Telephone:
(858) 453-4100 ext. 1891 (Director)
E-mail: GT3@salk.edu (For ordering information and request submission).
Mailing Address:
Salk Institute, GT3
10010 N Torrey Pines Rd
La Jolla, CA 92037-1099
Our offices are located just North of the Salk Institute in the Sanford Consortium for Regenerative Medicine building.
Office Location
Room 1318
Lab Location
Room 1106
